MetaCap

Bicycle Therapeutics Statistics

NASDAQ: BCYCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.90-0.15 (-4.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Bicycle Therapeutics by the numbers

Bicycle Therapeutics has a market capitalization of $203.3 million based on 50.66M shares outstanding. With trailing EPS of $-2.03, Bicycle Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% below its 50-day average and 33.1% below its 200-day average.

Average daily trading volume is 444.72K shares, or about $1.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BCYC valuation vs. peer median

BCYC compared with the median of 8 peer companies
MetricBCYCPeer medianDifference
Market cap$203.27M$199.89M+2%
Avg. volume444.72K560.96K-21%

Peer median across 8 companies: FTH, DRUG, NGEN, VNDA, BIOA, YARW, CYPH, ACIU.

Valuation

Market cap
$203.27M
Price / sales (latest FY)
2.80
EPS (TTM)
$-2.03

Price and trading

Previous close
3.05
Open
2.99
Day range
2.85 – 3.00
52-week range
2.85 – 7.83
52-week change
-54.11%
Beta
—
Volume
1.02M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
203.27M
Forward Pe
-1.21
Eps
-2.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.83
Week52 Low
2.85
Avg Volume
444.72K
Shares Outstanding
50.66M
Ma50
3.61
Ma200
4.33
Earnings Date
Oct 29, 2026
Pct From52w High
-62.96%
Pct From52w Low
1.75%

Related